Stage II-III Non-small Cell Lung Cancer
4 clinical trials · Condition
◉ Watch Stage II-III Non-small Cell Lung Cancer
| Record | Firm | Date |
|---|---|---|
| Phase III Study of Toripalimab Versus Placebo Plus Chemotherapy in Resectable NSCLC (NCT04158440) | Shanghai Junshi Bioscience Co., Ltd. | 2020-04-07 |
| Prophylactic PEG-rhG-CSF During cCRT in LA-NSCLC (NCT06958614) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2019-09-02 |
Track Stage II-III Non-small Cell Lung Cancer automatically
Every clearance here is in the API, with alerts when new ones post.